Iliac bone marrow findings and prognosis in MDS patients

Iliac bone marrow findings and prognosis in MDS patients

1.5 Second International Conference on Myelodysplastic Syndromes SECTION H - POSTER PRESENTATIONS Classification syndromes Histologic of the Myelod...

145KB Sizes 0 Downloads 66 Views

1.5

Second International Conference on Myelodysplastic Syndromes

SECTION H - POSTER PRESENTATIONS Classification syndromes Histologic

of the Myelodysplastic Criteria for their (MDS): Recognition.

Bertha Frisch Institute of

Aviv,

and Reiner

Bartl.

Haematology, Ichilov and Bon,e Marrow Diagnosis,

Hospital Tel Munich Univ.

In retrospective and prospective studies from 1975 to 1991, bone marrow biopsies, aspirates and clinical features of 495 patients with MDS were investigated. Sections of undecalcified plastic embedded biopsies and smears with of bone marrow aspirates were stained Giemsa. Bone marrows with MDS were characterised by three main categories of morphological alterations: 1)cellular abnormalities, P)architectural disorganisation of the bone marrow, 3)stromal changes; the combined use of aspirates and trephine biopsies enabled a more reliable and accurate diagnosis of MDS than either one alone. The bone marrow findings fell into one of with the frequencies and 7 subtypes, median survivals in brackets: 1)MDS sideroblastic(19X.62 months), 2)MDS megaloblastoid(l3X. 56 months), 3)MDS proliferative(22X,31months), 4)MDS blastic(l5%,9months). 5)MDS hypoplastic (15%.26months). 6)MDS fibrotic (6%.29 months), and7)MDS inflammatory(lOX.42 months).In follow with secondary MDS were up studies patients excluded and the prognosis and subsequent evolution for each of the morphological sub-

DISTURBANCES OF HAEMOPOIETIC ORGANISATION AND MATURATION IN MYELODYSPLASTIC SYNDROMES DEMONSTRATED BY DIFFERENTIAL STAINING WITH IMMUNOHISTOCHEMICAL MARKERS B S Wilkins, D B Jones University Dept of Pathology, Southampton General Hospital, SOUTHAMPTON SO9 4XY Antibodies showing restricted reactivity with individual haemopoietic cell lineages and/or maturation stages were used to stain bone marrow trephine biopsies representing primary myelodysplastic syndromes. Anti-alpha- and beta-sialoglycoprotein antibodies distinguished early and late erythroid precursors. Antibodies to CD68, CD15, muramidase, neutrophil elastase and calgranulin allowed differential staining of early and late granulocytes and monocytes. CD61 detected megakaryocytes. With these antibodies we were able to demon-strate marked spatial disturbances of haemopoietic cell organisation and to characterise many of the abnormal clusters of immature cells found in the myelodysplastic biopsies.

typeswere evaluated.The conclusionis drawn that aspirates and trephine biopsies are

complementary procedures and both are required for diagnosis, classification and decisions on current treatment modalities for patients with

MDS. ILIAC BONE hmROW FINDINGS AND PROGNOSIS IN MDS PATIENTS L.L.Yavorkoveky tine, RIGA)

(Latvian

Academy of

Medi-

A series of 58 patients with MDS were studied: RA.41 patients; RAEB,13 patients; IV.EB-t,4 patients. In this sequence of BIDS variants the following histologic findings tended to be more conuson: increased cellularity, presence of predominant cell type, abnormal localization of immature precursincluding those within sinusoors (ALIP), ids, marked perivascular plasurocytosis and fibrosis. Opposite tendency seemed obvious in respect of lymphoid nodules. Increased cellularity, predominant cell type (except erythroid), large number of ALIP and decreased number or striking features of ?egakaryocytes ? were of poor prognostic significance regardless of the LIDIDs type. The group of FAB-CAW patients (n-76) was shown to be not homogeneous. Bone marrow findingsvaried and were helpful ill

distinguishingat least three different entitieswith diverse prognosis:1) Iw and

HAEB with monocytosis (MDS subvariants), 2) myelomonocytic dysplasia (new MDS variant) and 3) true CMML (disorder other than MDS).

HAEMATOLOGICAL,

RAOIOLOGICAL

MYELOOISPLASTIC Resegotti

SYNOROHES

L, Depaoli

Giovinazzo

6.

University

of Torino,

Several

Avanzi

of

MDS

terms

of

marrow

histology

type

and

of

associated

and

nies.

Stimulation

cases

an

noic

acid

in

as

documented of

in

which

cells

cases

MD, and

the

uhereas

feu

IL3.

in

growth. an

it by

displayed

17

case.

clusters and

cell

inhibited

Epo

Semi-

and

no

induced

in

on

furacti-

analysis. were

normal

documented

all

growth

proliferative

alterations

of

colo-

transreti-

action

apparently WePe

always

differentiation; the

the

clusters

phase,

autoradiographic

an

noted

single

uas

of

in

of

frequent

a number

inhibitory

cytochemical

abnormalities

uas

Independently

liquid

28

between

thrombocytopenia.

GM-CSF

affecting

observed

neutropenia

In

of

concordance

most

or

and

a series

correlation

level.

anaemia

Cytogenetic evaluable

Epo

with

cases

Foggetti

radiological in

been

inverse

was

displayed

quarter

has

erythroid

thermore

IN

Hospital

complete

very

however, 5

A

produced

increase

0,

assessed

cultures

without,

vity

An

either

precursors,

STUDIES

Molinette

histological,

serum

feature,

vitro

.

been

anaemia

with

in

P, Davini R

diagnosis.

NMR.

MOS,

presentation

GM

Fo2

cellularity

anaemia

solid

Lista

have

at

BIOLOGICAL

Italy

features

cases

between

L, GC,

haematological,

biological

AND

(MM)

In

a

observed

morphology. in

6

of

the